You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Ear, nose and throat conditions

Dupilumab for treating severe chronic rhinosinusitis with nasal polyps (review of TA648) [ID6480]

  • In development
  • Reference number: GID-TA11630
  • Expected publication date:  29 October 2025
  • Project information
  • Project documents
  • Consultation

On this page

  1. Draft guidance
  2. Declaration of interests
  3. Invitation to participate
  4. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Documents

Documents created during the development process.

Draft guidance

  • Draft guidance

  • Draft consultation document (downloadable version) (PDF 255 KB)

    Published:
    23 July 2025
  • Draft consultation document (online commenting)

  • Equality impact assessment (downloadable version) (PDF 129 KB)

    Published:
    23 July 2025

Declaration of interests

  • Register of interests (PDF 110 KB)

    Published:
    04 July 2025

Invitation to participate

  • Final scope (PDF 123 KB)

    Published:
    19 November 2024
  • Final stakeholder list (PDF 130 KB)

    Published:
    19 November 2024
  • Equality impact assessment (downloadable version) (PDF 103 KB)

    Published:
    19 November 2024
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 278 KB)

    Published:
    19 November 2024

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

  • Draft scope post referral (MSWord 72 KB)

    Published:
    22 October 2024
  • Draft matrix post referral (MSWord 45 KB)

    Published:
    22 October 2024
Back to top